BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24852354)

  • 1. Recombinant interleukin-12, but not granulocyte-colony stimulating factor, improves survival in lethally irradiated nonhuman primates in the absence of supportive care: evidence for the development of a frontline radiation medical countermeasure.
    Gluzman-Poltorak Z; Vainstein V; Basile LA
    Am J Hematol; 2014 Sep; 89(9):868-73. PubMed ID: 24852354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Hematological Nadirs and Survival in a Nonhuman Primate Model of Hematopoietic Syndrome of Acute Radiation Syndrome.
    Gluzman-Poltorak Z; Vainstein V; Basile LA
    Radiat Res; 2015 Aug; 184(2):226-30. PubMed ID: 26207689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
    Farese AM; Casey DB; Smith WG; Vigneulle RM; McKearn JP; MacVittie TJ
    Stem Cells; 2001; 19(6):522-33. PubMed ID: 11713344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation.
    Gluzman-Poltorak Z; Mendonca SR; Vainstein V; Kha H; Basile LA
    J Hematol Oncol; 2014 Apr; 7():31. PubMed ID: 24708888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia.
    Farese AM; Hunt P; Grab LB; MacVittie TJ
    J Clin Invest; 1996 May; 97(9):2145-51. PubMed ID: 8621805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor.
    MacVittie TJ; Farese AM; Herodin F; Grab LB; Baum CM; McKearn JP
    Blood; 1996 May; 87(10):4129-35. PubMed ID: 8639770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effect of rmIL-12 combined with G-CSF on acute radiation sickness produced by γ-ray irradiation in mice].
    Wang L; Zhai RR; Pang ZX; Zhang C; Yu CL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):995-9. PubMed ID: 22931671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte colony-stimulating factor administered as a single intraperitoneal injection modifies the lethal dose95/30 in irradiated B6D2F1 mice.
    Sureda A; Kádár E; Valls A; García-López J
    Haematologica; 1998 Sep; 83(9):863-4. PubMed ID: 9825589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice.
    Shibuya K; Akahori H; Takahashi K; Tahara E; Kato T; Miyazaki H
    Blood; 1998 Jan; 91(1):37-45. PubMed ID: 9414267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia.
    Patchen ML; Fischer R; MacVittie TJ
    Exp Hematol; 1993 Feb; 21(2):338-44. PubMed ID: 7678816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
    Tanikawa S; Nakao I; Tsuneoka K; Nara N
    Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression.
    MacVittie TJ; Farese AM; Smith WG; Baum CM; Burton E; McKearn JP
    Blood; 2000 Feb; 95(3):837-45. PubMed ID: 10648394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of autologous cell therapy and granulocyte-colony stimulating factor (G-CSF) injection vs. G-CSF injection alone for the treatment of acute radiation syndrome in a non-human primate model.
    Bertho JM; Frick J; Prat M; Demarquay C; Dudoignon N; Trompier F; Gorin NC; Thierry D; Gourmelon P
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):911-20. PubMed ID: 15913916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic Effect of Combined Cytokines on Nonhuman Primate Model of Severe Haemopoietic Acute Radiation Sickness].
    Ma YC; Li M; Xing S; Xiong GL; Shen X; Chen Q; Cong YW; Wang JX; Zhu NK; Yu ZY; Zhang XG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):573-9. PubMed ID: 27151032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEG-G-CSF and L-Citrulline Combination Therapy for Mitigating Skin Wound Combined Radiation Injury in a Mouse Model.
    Wang L; Zhai M; Lin B; Cui W; Hull L; Li X; Anderson MN; Smith JT; Umali MV; Jiang S; Kiang JG; Xiao M
    Radiat Res; 2021 Jul; 196(1):113-127. PubMed ID: 33914884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells.
    Neelis KJ; Dubbelman YD; Qingliang L; Thomas GR; Eaton DL; Wagemaker G
    Exp Hematol; 1997 Sep; 25(10):1084-93. PubMed ID: 9293906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of efficacy of thrombopoietin and granulocyte colony-stimulating factor after high dose total-body irradiation and autologous stem cell or bone marrow transplantation in rhesus monkeys.
    Neelis KJ; Dubbelman YD; Wognum AW; Thomas GR; Eaton DL; Egeland T; Wagemaker G
    Exp Hematol; 1997 Sep; 25(10):1094-103. PubMed ID: 9293907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor.
    Monroy RL; Skelly RR; Taylor P; Dubois A; Donahue RE; MacVittie TJ
    Exp Hematol; 1988 Jun; 16(5):344-8. PubMed ID: 3286278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.